International Nonproprietary Name: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
(New section, 'Name stems', copied with minor modification from Wikipedia)
 
Line 4: Line 4:
'''INN'''s facilitate communication by providing a standard name for each substance. A similar role is played in [[chemistry]] by [[IUPAC name]]s; however, these are less suited to common usage, being typically very long and unwieldy.
'''INN'''s facilitate communication by providing a standard name for each substance. A similar role is played in [[chemistry]] by [[IUPAC name]]s; however, these are less suited to common usage, being typically very long and unwieldy.
WHO issues INN names in English, Latin, French, Russian, and Spanish; Arabic and Chinese versions, although not included in the original scheme, are now also being issued.
WHO issues INN names in English, Latin, French, Russian, and Spanish; Arabic and Chinese versions, although not included in the original scheme, are now also being issued.
==Name stems==
Drugs from the same therapeutic or chemical class are usually given names with the same ''[[word stem|stem]]''. Stems are mostly placed word-finally, but in some cases word-initial stems are used. They are collected in a publication informally known as the ''Stem Book''.<ref name="StemBook">{{cite web | publisher=World Health Organization | url=http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf | deadurl=no | format=PDF | title=The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances | year=2011 | accessdate=21 March 2014 | id=WHO/EMP/QSM/2011.3 | archivedate=26 October 2013 | archiveurl=https://web.archive.org/web/20131026230242/http://www.who.int/medicines/services/inn/StemBook_2011_Final.pdf }}</ref>
Example stems are:<ref name="StemBook" />
* ''-anib'' for [[angiogenesis]] inhibitors (e.g. [[pazopanib]])
* ''-anserin'' for [[serotonin]] receptor antagonists, especially [[5-HT2 receptor|5-HT<sub>2</sub>]] antagonists (e.g. [[ritanserin]] and [[mianserin]])
* ''-arit'' for antiarthritic agents (e.g. [[lobenzarit]])
* ''-ase'' for [[enzymes]] (e.g. [[asparaginase]])
* ''-azepam'' for [[benzodiazepines]] (e.g. [[diazepam]] and [[oxazepam]])
* ''-caine'' for [[local anaesthetics]] (e.g. [[procaine]] or [[cocaine]])
* ''-cain-'' for class I [[antiarrhythmics]] (e.g. [[procainamide]])
* ''-coxib'' for [[Cyclooxygenase-2|COX-2]] inhibitors, a type of [[anti-inflammatory drug]]s (e.g. [[celecoxib]])
* ''-mab'' for [[monoclonal antibodies]] (e.g. [[infliximab]]);
** see [[Nomenclature of monoclonal antibodies]]
* ''-navir'' for antiretroviral [[protease inhibitors]] (e.g. [[darunavir]])
* ''-olol'' for [[beta blocker]]s (e.g. [[atenolol]])
* ''-pril'' for [[ACE inhibitors]] (e.g. [[captopril]])
* ''-sartan'' for [[angiotensin II receptor antagonist]]s (e.g. [[losartan]])
* ''-tinib'' for [[tyrosine kinase inhibitor]]s (e.g. [[imatinib]])
* ''-vastatin'' for [[HMG-CoA reductase inhibitor]]s, a group of cholesterol lowering agents (e.g. [[simvastatin]])
* ''-vir'' for [[Antiviral drug|antiviral]]s (e.g. [[aciclovir]] or [[ritonavir]])
* ''arte-'' for [[artemisinin]] antimalarials (e.g. [[artemether]])
* ''cef-'' for [[cefalosporin]]s (e.g. [[cefalexin]])
* ''io-'' for [[iodine]]-containing [[radiopharmaceutical]]s (e.g. [[iobenguane]])


==Example==
==Example==
{|
{|
|'''INN''': || [[Paracetamol]]
|'''INN''': || [[Paracetamol]]

Latest revision as of 02:45, 26 November 2016

Overview

An International Nonproprietary Name (INN; also known as rINN, for recommended International Nonproprietary Name) is the official non-proprietary or generic name given to a pharmaceutical substance, as designated by the World Health Organization (WHO). The plethora of named proprietary preparations containing a given substance can lead to confusion about the identity of the active ingredient. INNs facilitate communication by providing a standard name for each substance. A similar role is played in chemistry by IUPAC names; however, these are less suited to common usage, being typically very long and unwieldy. WHO issues INN names in English, Latin, French, Russian, and Spanish; Arabic and Chinese versions, although not included in the original scheme, are now also being issued.

Name stems

Drugs from the same therapeutic or chemical class are usually given names with the same stem. Stems are mostly placed word-finally, but in some cases word-initial stems are used. They are collected in a publication informally known as the Stem Book.[1]

Example stems are:[1]

Example

INN: Paracetamol
British Approved Name (BAN): Paracetamol
United States Adopted Name (USAN): Acetaminophen
Other generic names: N-acetyl-p-aminophenol, APAP, p-Acetamidophenol, Acetamol, ...
Proprietary names: Tylenol®, Panadol®, Panamax®, Perdolan®, Calpol®, Doliprane®, Tachipirina®, ben-u-ron®,Atasol®, and others
IUPAC name: N-(4-hydroxyphenyl)-acetamide

See also

External links


cs:Mezinárodní nechráněný název de:International Nonproprietary Name it:Denominazione comune internazionale hu:Nemzetközi szabadnév (gyógyszer) nl:International Nonproprietary Name no:INN-klassifikasjon th:INN

Template:WH Template:WikiDoc Sources

  1. 1.0 1.1 "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). World Health Organization. 2011. WHO/EMP/QSM/2011.3. Archived (PDF) from the original on 26 October 2013. Retrieved 21 March 2014.